Voluntary Disclosure of Socio-Economic Issues by JSE Listed Companies: The HIV/AIDS Example
Thabang Mokoaleli-Mokoteli and
Kalu Ojah ()
The African Finance Journal, 2010, vol. 12, issue 2, 1-26
Possible economic consequences of HIV/AIDS include: increased risk of group life cover, retirement benefit and medical care costs; increased cost of labour due to high staff turnover, absenteeism and compassionate or sick leave; and cost of HIV/AIDS management programs. Given the exposure of most South African firms to these costs, this research examines the extent to which publicly listed firms voluntarily disclose information about HIV/AIDS. It equally ascertains factors that influence firms to voluntarily disclose such socially sensitive but economically consequential information. Results show that firm listing, firm size and belonging to the industrial sector are important in influencing firms to disclose information about HIV/AIDS. These results largely support the notion that firms with reputational capital are generally forthcoming with economically important information.
Keywords: voluntary disclosure; annual reports; HIV/AIDS; JSE; South Africa (search for similar items in EconPapers)
JEL-codes: G1 G3 D8 (search for similar items in EconPapers)
References: Add references at CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:afj:journl:v:12:y:2010:i:2:p:1-26
Access Statistics for this article
More articles in The African Finance Journal from Africagrowth Institute Contact information at EDIRC.
Bibliographic data for series maintained by Kirk De Doncker ().